Various physiologically relevant processes are regulated by the interaction of the receptor tyrosine kinase (c-Kit) and its ligand stem cell factor (SCF), with SCF known to be the most important growth factor for mast cells (MCs). In spite of their traditional role in allergic disorders and innate immunity, MCs have lately emerged as versatile modulators of a variety of physiologic and pathologic processes. Here we show that MCs are critical for pregnancy success. Uterine MCs presented a unique phenotype, accumulated during receptivity and expanded upon pregnancy establishment. Kit W-sh/W-sh mice, whose MC deficiency is based on restricted c-Kit gene expression, exhibited severely impaired implantation, which could be completely rescued by systemic or local transfer of wild-type bone marrow-derived MCs. Transferred wild-type MCs favored normal implantation, induced optimal spiral artery remodeling and promoted the expression of MC proteases, transforming growth factor-b and connective tissue growth factor. MCs contributed to trophoblast survival, placentation and fetal growth through secretion of the glycan-binding protein galectin-1. Our data unveil unrecognized roles for MCs at the fetomaternal interface with critical implications in reproductive medicine.
The interplay between the receptor tyrosine kinase c-Kit (CD117) and its ligand stem cell factor (SCF) is essential for various processes like regulation of proliferation, differentiation and survival of hematopoietic cells, germ cells and melanocytes. 1 It further promotes cell adhesion, 2 spermatogenesis, 3 oogenesis and folliculogenesis. 4 In many cell types, including B and T cells, the expression of c-kit is downregulated upon cell differentiation, suggesting a role of other growth factors like, for example, BAFF (B-cell activating factor) for B cells 5 or transforming growth factor-b (TGF-b) for T cells 6 for their development and differentiation. However, mast cells (MCs), natural killer (NK) cells, dendritic cells (DCs) and decidual macrophages retain c-Kit expression. 7 At the fetomaternal interface, c-Kit is highly expressed in the decidua (maternal part) as well as in the placenta (fetal part). 8, 9 A point mutation in the tyrosine kinase domain of the Kit-receptor 10 in WBB6F 1 -W/W v mice results in severe pathologic abnormalities and infertility, 11, 12 whereas an inversion mutation of the kit gene 13 in Kit W-sh/W-sh mice has less severe effects, with the mice being reportedly fertile. 14 Besides their profound deficiency in MC populations, other immune cells are not affected as Kit W-sh/W-sh displayed normal levels of B cells, T cells, macrophages, DCs, peripheral NKs and basophils, 15 probably due to the expression of c-Kit in the hematopoietic stem cells of Kit W-sh/W-sh mice. 16 Therefore, these mice represent a powerful tool to investigate the influence of MC deficiency, caused by a defective c-Kit signaling on pregnancy-relevant processes.
MCs are widely known as effector cells responsible for mediating allergic disorders and innate immunity. However, emerging evidence has identified a central role for these cells in the development and establishment of adaptive immune responses, as they are able to produce a variety of both proand anti-inflammatory mediators. 17 MCs are present in the myometrium, endometrium and cervix from humans and rodents, where they preferentially localize around blood vessels. [18] [19] [20] [21] [22] Little is known, however, about the functional contribution of MCs to uterine remodeling and, thus, to pregnancy establishment and the mechanisms underlying this effect. As implantation of the blastocyst into the maternal endometrium requires substantial tissue remodeling and MCs are a rich source of biologically active mediators, 17, 23 we hypothesized that MCs may be important players in pregnancy establishment and maintenance.
Early morphological observations suggest an association of MCs and histamine release with ovum implantation. 24 The in vivo exposure to MC stabilizers, which inhibit their degranulation, resulted in decreased uterine endothelial cell proliferation and reduced vascular endothelial growth factor-A (VEGF-A) secretion. 21 In addition, we have recently shown that MCs degranulate in the uterus in response to hormone stimulation. 25 Pregnant women affected by systemic mastocytosis or asthma exhibit manifestations of preterm labor and delivery. 26 Recent studies, however, discarded a participation of MCs in the induction of labor in a mouse model. 27 We undertook the present study using MC-deficient Kit W-sh/W-sh mice, whose MC deficiency is caused by a defective c-Kit gene expression, to characterize the role of MCs in pregnancy success and to dissect the mechanisms underlying the modulatory functions of these cells.
Results
Uterine MC numbers increased during the fertile period of the estrous cycle. We first analyzed the number of uterine MCs throughout the estrous cycle and early pregnancy. MC numbers were highest during the fertile phase of the cycle, namely in estrus when the female is sexually receptive and the endometrium is prepared for nidation (Figures 1a and b ). MC numbers were even higher on days 2 and 5 of gestation ( Figure 1a ), but declined rapidly if fecundation did not occur (metestrus). As mast cell deficiency in Kit W-sh/W-sh is caused by a defective c-Kit signaling and c-Kit/c-Kit ligand interaction is important for oocyte development and folliculogenesis, 4 we monitored the estrous cycle in these mice. Sexually mature Kit W-sh/W-sh showed a normal estrous cycle in respect to time duration with clearly distinguishable phases. Besides, MCs were not critical for ovulation as shown by similar number of corpora lutea in MC-deficient Kit W-sh/W-sh and their wild-type counterparts ( Supplementary Figure 1) .
Uterine MCs revealed a unique phenotype and were located close to blood vessels at implantation sites. We next examined the presence of MCs in allogeneic implantation sites of wild-type mice. MCs locate in between the implantation sites ( Figure 1c ). At midpregnancy, MCs were present in high numbers at the maternal side of the fetalmaternal interface and in general mainly localized close to blood vessels (Figures 1d and e, f, i). A detailed characterization of uterine MCs revealed that they represent a heterogeneous population containing connective tissue MCs (Figure 1f ii), mucosal MCs (Figure 1f , iii) and MCs undergoing different stages of differentiation or transdifferentiation 28 (Figure 1f , iv). The uterine MC population was positive for CD117 ( Figure 1f , v-vi) and mast cell protease 8 (Mcpt8; Figure 1f , vii-viii, and Supplementary Figure 2a ), while the percentage of uterine MCs expressing Mcpt5 oscillated between 5-20%, as shown using isolated uterine cells from Mcpt5-Cre ROSA26 EYFP mice (C57BL/6J background; 29 Supplementary Figure 2b ). Thus, uterine MCs represent a heterogeneous population characterized by a distinctive phenotype.
Kit W-sh/W-sh , c-Kit deficient mice, present a phenotype of aberrant implantation that can be completely reverted by systemic or local transfer of wild-type MCs. To analyze implantation, Kit W-sh/W-sh females (C57BL/6J background) were mated with BALB/c males, because allogeneic matings represent natural, biologically relevant combinations compared with, for example, syngeneic ones. MC deficiency was related with significantly less implanted blastocysts compared with wild types (median ¼ 0, n ¼ 23 versus median ¼ 9, n ¼ 19, Po0.05; Table 1a and Figure 2a ). Uteri from Kit W-sh/W-sh mice were swollen and reddish with no implantations (Figure 2a iii), or contained few macroscopically normal implantations (Figure 2a iv). Implantation was also impaired in the context of a syngeneic combination ( Supplementary  Table 1 ) and litter size in Kit W-sh/W-sh mice was significantly reduced (Supplementary Table 2 ). Reconstitution of Kit W-sh/W-sh mice with bone marrow-derived wild type and therefore c-Kit-expressing mast cells (BMMCs) completely restored the numbers of implantations and litter size (median: 7, n ¼ 17; Table 1 and Figure 2a , v). Systemic MC transfer successfully reconstituted the MC compartment in lymph nodes draining the fetal-maternal unit (Figure 2b ), inguinal and mesenteric lymph nodes (Figures 2c and d) , and the decidua (Figure 2e ). As the development of all hematopoietic stem cells is dependent on SCF, the c-Kit ligand, it would be possible that other immune cell populations could be affected by the defective c-Kit signaling in the Kit W-sh/W-sh model. However, BMMC transfer did not lead to relevant changes in the frequency of T helper cells, NK cells, cytotoxic T cells or activated dendritic cells in spleen, lymph nodes, blood or decidua (data not shown), excluding the possibility that these immune cells could be responsible for the observed effects after reconstitution. This could be explained by the detected c-Kit expression in hematopoietic stem cells of Kit W-sh/W-sh . 16 Notably, uterine NKs were augmented in Kit W-sh/W-sh animals compared with controls (data not shown), suggesting an interplay between these two cell types and a possible counterregulatory effect. Neutrophils were not analyzed.
As reconstitution with BMMCs normalized the peripheral and local MC compartment, we next examined whether uterine MCs are critical for implantation. We locally transferred BMMCs into one horn of the bicorneal uterus of Table 2 ). Although a significantly higher number of blastocysts were implanted in the MC-reconstituted uterine horn ( Table 2) , all females had at least one implantation on the mock-treated site ( Supplementary Figures 3 and 5 ). This effect is most likely explained by the fact that these sites, which are directly adjacent to the MC-reconstituted uterus horn, also showed MCs ( Supplementary Figure 5b MC transfer into c-Kit-deficient mice promoted remodeling of spiral arteries: correlation with changes in Mcpts, TGF-b1 and CtGF. To gain insights into the mechanisms underlying MC modulatory activity, we further examined their effect on tissue remodeling that is manifested by the ability of blastocysts to implant. At day 5, implantations of different sizes could be observed (Supplementary Figure 6 ). Those few implantations that succeeded in Kit W-sh/W-sh females were significantly smaller at day 5, at which implantation should be finished ( Figure 3a ) and their development was significantly delayed (Figure 3b ). Smaller implantations reflect defective nidation or even embryos that may not further develop 30 and derive thus in less or no embryos at later pregnancy stages. BMMC transfer further resulted in significantly augmented size and timely development of implantations (Figures 3c and d ). Successful implantation requires both tissue remodeling and angiogenesis. These processes involve the inducible expression of several mediators including VEGF-A, matrix metalloproteinase 9 (MMP-9), plasminogen activator inhibitor 1 (PAI-1), urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA), TGF-b1 and CtGF, many of them synthesized by MCs. 31 We found that although mRNA levels for uPA, tPA, VEGF-A, MMP-9 and PAI-1 augmented following MC transfer, this upregulated expression, however, did not account for the 'loss-of-function' phenotype as no significant differences could be observed between wild-type and MC-deficient animals ( Supplementary Figures 7a-e ). This might be alternatively due to a compensation process based on the augmented number of uNK cells, which synthesize all these factors.
MC chymases are known to be effector molecules of MCs that further activate other factors involved in tissue remodeling. 32,33 mRNAs for Mcpts 1, 5 and 8, which were barely expressed in the decidua of Kit W-sh/W-sh MC-deficient mice, were highly expressed following BMMC transfer ( Supplementary Figures 8a-c) . The mRNA expression of TGF-b1 and connective tissue growth factor (CtGF), both proangiogenic molecules relevant for tissue remodeling, was significantly diminished at the fetal-maternal interface of c-Kit-deficient mice and BMMC transfer restored these cytokine levels (Figures 3e and f ). TGF-b1 was expressed by both MCs and trophoblasts ( Figure 3g ). In vitro, BMMCs secrete higher amounts of TGF-b1 than placenta explants as measured by ELISA (data not shown). CtGF was exclusively produced by trophoblasts and MCs showed high expression of TGF-b receptors (Figure 3g ). This suggests a regulatory loop. Of note, positive correlations between TGF-b1, CtGF and Mcpt8 were detected ( Supplementary Figures 9a-c) . Thus, MCs contribute to tissue remodeling that allows implantation and normalize the TGF-b/CtGF axis at the trophoblast/MC interface. Impaired implantations in c-Kitdeficient mice may result in improper placentation and fetal development. 30 In fact, MC-deficient mice exhibited significantly smaller placentas at day 10 of pregnancy ( Figure 4a -c , quantified in Figure 4d ). A more in-depth examination (Figure 4h and i) and resulted in increased placental surface area (Figure 4d ). This observation was critical, as a narrow lumen implies a defective oxygen and nutrient transport to the fetus, which can have fatal consequences for placental and fetal development.
Collectively, these data confirm that MCs normalize pregnancy in c-Kit-deficient mice by positively influencing spiral artery remodeling, placentation and, thus, fetal growth.
Galectin-1 is secreted by MCs and mediates their positive effects on placentation and fetal growth. To further understand the mechanisms underlying MC-associated normalization of placentation, we next focused our attention on galectin-1 (Gal-1) that has emerged as a regulator of pregnancy 34 and is abundant in human and mouse reproductive tracts. 35 Given the role of Gal-1 in trophoblast survival and syncytium formation, 36 Figure 5d ). GCs showed abnormalities including several vacuoles in their cytoplasm (Supplementary Figure 10) . In vivo, an incomplete reconstitution with MCs in the uterus and the draining lymph nodes was observed if Lgals1 À / À BMMCs were transferred (Supplementary Figure 11 ). In addition, Gal-1 deficiency in MCs led to decreased expansion of these cells in the presence of trophoblast cells in vitro ( Supplementary Figure 12) . This strongly suggests a defective proliferation of MCs in the uterus and/or incomplete migration of MCs to the uterus if they lack Gal-1.
Lgals1 À / À mice presented shallow spiral artery remodeling and altered placentation that could be rescued by the transfer of wild-type MCs. Spiral arteries from Lgals1 À / À females were characterized by increased wall/ lumen ratio ( Supplementary Figure 13a ), wall thickness ( Supplementary Figure 13b ) and lumen diameter ( Supplementary Figure 13c) , which pointed to abnormal vessel function. Lgals1 À / À mice had smaller implantation sizes at day 5 of pregnancy, which were comparable to those observed in Kit W-sh/W-sh mice (Supplementary Figure 14) . The importance of MCs secreting Gal-1 in supporting pregnancy and fetal growth was underlined by the fact that the adoptive transfer of BMMCs from wild-type animals into Lgals1 À / À mice provoked a statistically significant reduction in the abortion rate from 18.8 to 0% (P ¼ 0.0014; Table 3b and Figure 5e ). Thus, MC-derived Gal-1 may serve to promote expansion of these cells in an autocrine or paracrine manner and to sustain trophoblast survival, placentation and successful pregnancy.
Discussion
Adoptive transfer experiments in Kit W-sh/W-sh revealed central roles of MCs in implantation and fetal survival by mediating spiral artery formation and placentation, both critical events that ensure optimal fetal development.
MCs are present in the female reproductive tract, 19, 21, 22 yet the function of these cells in reproductive biology is uncertain. In pregnant rats, MC degranulation has positive effects on cervical angiogenesis. 20 Menzies et al. 27 recently reported no role for these cells in labor in a syngeneic context. Yet, the involvement of these cells during early pregnancy and in a biologically relevant allogeneic context has not been studied. We found that a transient population of uterine MCs appears in cycles and as a unique population composed of connective tissue-type MCs, mucosal MCs and a transitional population that share features of both phenotypes. The number of uterine MCs peaks at the fertile phase of the estrous cycle and remaining high if pregnancy establishes. MCs are abundant in the uterus during early pregnancy. This appears to be regulated through endocrine mechanisms, which is not surprising as they express estrogen and progesterone receptors. 37 We recently found that estradiol and progesterone promote MC migration from the periphery to the uterus. 25 To investigate the role of MCs in pregnancy, we used C57BL/6J-Kit W-sh/W-sh mice. Although MC deficiency in this particular model is caused by a defective c-Kit signaling that could further influence other signaling pathways, this model is well established and highly accepted. Although Kit W-sh/W-sh mice were described as fertile, 12 the maintenance of their colonies is difficult because of irregular birth rates and high natal and postnatal death rates. Allogeneically mated Kit W-sh/W-sh mice show severely impaired implantation, although single mice may present normal litter size that account for their ability to breed. These single mice appear to carry their fetuses to term, an observation already made by Menzies et al. 27 in a syngeneic context. The transfer of wildtype BMMCs could completely rescue the impaired reproductive phenotype. We demonstrate that MCs are present at the fetal-maternal interface after systemic and local reconstitution, suggesting that MCs act locally to foster normal pregnancy. Recently, c-Kit-independent models have been described, including a model that relies on the expression of Mcpt5 by MCs. 38 Notably, we found that only 5-20% of uterine MCs express Mcpt5, suggesting that 80% of MCs would not be depleted following diphtheria toxin administration. These results would also preclude using recently generated a-chymase-Cre transgenic mice (Chm/Cre) whose Cre expression correlates to resident mucosal, but not to connective tissue-type MCs. 39 In general, the generation of novel mouse models, whose MC deficiency is independent of a c-Kit-mutation, 38, 40 offer new insights in MC biology, but their relevance for different systems must be individually examined.
MC chymases Mcpt1, Mcpt5 and Mcpt8 were present at high levels in Kit W-sh/W-sh mice after systemic and local transfer. As chymases contribute to matrix degradation, tissue remodeling and angiogenesis, 31 a new concept emerges, which implies MCs as essential initiators of tissue remodeling during pregnancy. We show that MC deficiency results in severely impaired implantation followed by defective spiral artery remodeling, effects that are restored by MC reconstitution. Analysis of c-Kit-deficient uteri during implantation revealed blastocysts at different implantation stages. Measurement of the attached blastocysts revealed smaller sizes and a delayed kinetic than the wild types. These results are worthwhile to be discussed in terms of the fatal impact of delayed implantation in pregnancy outcome. 30 The phenotype of Kit W-sh/W-sh mice may be attributable to the activation of MC proteases that stimulate other mediators involved in tissue remodeling and/or angiogenesis; these include tPA, uPA, PAI-1, VEGF-A, MMP9, tryptase and chymase. 17, 31, 41, 42 Systemic and local MC reconstitution of Kit W-sh/W-sh mice led to increased uterine expression of several molecules, for example, uPA and tPA, both related to implantation. 41 In line with this evidence, mice lacking uPA and tPA suffer from extensive fibrin deposition with impaired organ function, loss of fertility and reduced survival. 43 PAI-1, known to have an essential role in tissue remodeling, 44 was also augmented following MC reconstitution. Interestingly, PAI-deficient mice presented similar placental morphology like Lgals-1 À / À mice. 44 In this context, MC proteases may be more relevant as c-Kit-deficient mice have comparable PAI-1, uPA, tPA, VEGF-A and MMP-9 levels but significantly less Mcpts than wild types. We found that MCs are involved in the interplay between CtGF and TGF-b1. CtGF has been implicated in matrix production during the menstrual cycle, uterine cell growth, 45 implantation, development and differentiation of the embryo, 46 extracellular matrix (ECM) synthesis and angiogenesis. 47 TGF-b1 mRNA was described in mouse tissues including placenta and developing mouse fetus. 48 TGF-b-null mice develop a multiorgan autoimmune inflammatory disease leading to organ failure and rapid death after birth. 49 In our system, trophoblasts and MCs were sources of TGF-b1 whereas its receptor was highly expressed in MCs. We speculate that, as a consequence of a dysregulated TGF-b1/CtGF axis, thicker spiral artery walls are generated, leading to narrow lumen and inadequate fetus supply. In our model, these abnormalities were prevented upon reconstitution with wild-type BMMCs. Importantly, although lethality of mice lacking TGF-b1 or CtGF precludes the possibility of analyzing the pathophysiologic relevance of these molecules in the context of MC deficiency, a strong positive correlation among MC-derived Mcpts, TGF-b1 and CtGF could be confirmed.
The glycan-binding protein Gal-1 regulates multiple events associated with successful pregnancy, including trophoblast growth, syncytium formation and angiogenesis. [35] [36] [37] We confirmed here that MCs produce and secrete Gal-1. To the best of our knowledge, this is the first report implying MCs as a major source of Gal-1. Decidual tissue obtained from MCdeficient animals showed lower expression of Gal-1 that was restored after BMMC reconstitution. In vivo, adoptive transfer of Kit W-sh/W-sh animals with Lgals1 À / À BMMCs resulted in incomplete reconstitution of the uterus with MCs. Thus, Gal-1 is important for the expansion of MCs in the uterus as also suggested by our in vitro experiments or for their migration to the fetomaternal interface. Transfer of Lgals1 À / À BMMCs resulted in higher number of fetal death as compared with mice reconstituted with wild-type BMMCs, confirming the critical role of Gal-1 secreted by MCs. Placentas from surviving embryos derived from Kit W-sh/W-sh mice transferred with Lgals1 À / À MCs showed altered placentation. Gal-1, secreted by MCs, substantially contributed to placentation and pregnancy success. Similar to Kit W-sh/W-sh mice, spiral arteries from Lgals1 À / À mothers were insufficiently remodeled, supporting the critical role of Gal-1 as a mediator of MC protective function. This was confirmed by experiments in which pregnant Lgals1 À / À mice were transferred with Gal-1expressing BMMC, which completely abrogated fetal death. Our data clearly show that Gal-1 secreted by MCs contributes to normal placentation through nonimmunological mechanisms.
Our data demonstrate that MCs play central roles in pregnancy by allowing tissue remodeling during implantation Table 3b Number of implantations per females as well as mean and median of abortion rate after detection of a definite vaginal plug (C57BL/6, Lgals1 À / À and Lgals1 À / À reconstituted with BMMCs generated from C57BL/6J after allogeneic mating with BALB/c males on day 10 of pregnancy (data of implantations/females are given as mean and median in parentheses) and/or by positively influencing placentation and fetal growth. These findings may help to delineate cellular mechanisms that govern successful pregnancies with potential applications to other biomedical fields.
Implantations
Materials and Methods Animals. To investigate the possible role of MCs in vivo in mouse pregnancy, we used MC-deficient C57BL/6J-Kit W-sh/W-sh mice. W-sash (W sh ) is an inversion mutation in the transcriptional regulatory elements upstream of the c-kit transcription start site on mouse chromosome 5. 13 W sh mutation results in very few developmental abnormalities, and until very recently the only reported phenotypic abnormalities in Kit W-sh/W-sh mice were an impairment of skin pigmentation and a MC deficiency in the skin and peritoneal cavity. 50 However, MC deficiency after the age of 10 weeks becomes more profound with abnormalities reported in multiple anatomical sites. 50 In all the experiments reported here, we used animals older than 10 weeks to assure MC deficiency. The present study was authorized by the German Ministry and carried out according to institutional guidelines of Berlin and Magdeburg (LaGeSo, Berlin, Germany, Reg. no. 0070/03; 203.h-42502-2-868 Magdeburg) and the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching, USA. BALB/c male mice were purchased from Charles River (Sulzfeld, Germany). C57BL/6J-Kit W-sh/W-sh MC-deficient females were obtained from Jackson Laboratories (Bar Harbor, ME, USA). Wild-type counterparts C57BL/6J were purchased from Charles River. Lgals1 À / À mice were provided by Dr. F Poirier (Jacques Monod Institute, Paris, France) and bred at the Animal Facilities of the Medical Faculty, Otto-von-Guericke University (Magdeburg, Germany). Animals were maintained in our barrier animal facility with a 12-h light/dark cycle. All females were checked daily for vaginal plugs. The day at which the vaginal plug was detected was considered as day 0 of pregnancy and the females were separated from the males. The BALB/c-mated Kit W-sh/W-sh , BL/6 and Lgals1 À / À BMMCreconstituted Kit W-sh/W-sh , Lgals1 À / À and control C57BL/6J females were killed on days 5, 6 or 10 of pregnancy or for the local reconstitution between days 10 and 12 of pregnancy, and the uteri were removed and the implantation sites were documented.
The determination of the estrous cycle in virgin C57/BL6 females was performed by vaginal lavage with 0.9% sodium chloride. The stage of the cycle was defined based on the typical cell content of the lavage. Females were killed when they showed a clear stage. To confirm the stage, samples were stained with hematoxylin/ eosin and analyzed under light microscopy. The state of the cycle was defined based on the characteristic cell content in the fresh lavage (Axiovert 40C, Carl Zeiss, Jena, Germany; magnification Â 200) and stained (Axio Observer.A1, Carl Zeiss; magnification Â 200).
Isolation, culture and adoptive transfer of BMMCs. Bone marrow cells were collected from femurs and tibias of wild-type C57BL/6J or Lgals1 À / À females and cultured in IMDM (Iscove's modified Dulbecco's medium) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 30 ng/ml murine recombinant IL-3 (final, Invitrogen, Carlsbad, CA, USA) or 10 ng/ml WEHI-3-derived IL-3 for at least 5 weeks, at which time 495% of the cells were identified as BMMCs by flow cytometric analysis of CD117 þ FceRIa þ cells ( Supplementary Figure 15 ).
For systemic MC reconstitution studies, BMMCs were transferred into 10-weekold Kit W-sh/W-sh females by i.v. injection of 5 Â 10 6 cells in 200 ml of PBS in the morning of two consecutive days (in total 1 Â 10 7 cells) through the tail vein. For local reconstitution, 1 Â 10 6 BMMCs were injected into different sections of the right uterine horn of Kit W-sh/W-sh females, whereas the left uterine horn served as control and was mock-treated. At 12 weeks after systemic and 5 weeks after local transfer (reported time required for biological and physiological reconstitution), BMMCreconstituted Kit W-sh/W-sh females were allogenically mated with BALB/c males. Simultaneously, age-matched MC-deficient Kit W-sh/W-sh and control C57BL/6J females were mated with BALB/c males.
Sample collection. On day 10 of pregnancy, one implantation site per female was collected for cryosections and one implantation site was collected for paraffin studies with previous fixation in 4% (w/v) PFA with 0.1 M sucrose (pH 7.4) for 6 h. The uterine horns were opened longitudinally and the fetal-placental unit carefully separated from the decidua. For flow cytometry analysis, decidual samples were cut in small pieces and collected in Hanks' balanced salt solution containing no Ca 2 þ or Mg 2 þ (Sigma, Taufkirchen, Germany). For RNA isolation or cell extract preparation for western blot analysis, tissues from placenta, decidua, spleen, thymus and lymph nodes (inguinal, axillary, mesenteric and iliac) were carefully washed with cold sterile PBS, pH 7.40, snap-frozen, and kept at À 80 1C until use. When analyzing uteri from day 5 or 6 of pregnancy, females were injected i.v. with Chicago Blue dye a few minutes before killing the animal, and uterine horns were dissected and fixed in 96% (v/v) ethanol.
Flow cytometry. Tissues from decidua, spleen, thymus and lymph nodes (inguinal, axillary, mesenteric and iliac) were processed as described 51 and stained with the following antibodies: FITC-conjugated anti-mouse FceRIa, PEconjugated anti-mouse CD117, PE-conjugated rat anti-mouse I-A/I-E (MHCII), PerCP-Cy5.5-conjugated rat anti-mouse CD4, PE-Cy5-conjugated rat anti-mouse CD8a, APC-conjugated hamster anti-mouse CD11c, FITC-conjugated hamster anti-rat CD49b (which also reacts with mouse CD49b), FITC-conjugated Mcpt8 and Alexa Fluor 647-conjugated anti-mouse Foxp3. All antibodies were purchased from Becton Dickinson (BD, Heidelberg, Germany). The FceRIa antibody was from eBioscience (Kranenburg, Germany). For Mcpt8 staining a Biolegend (Fell, Germany) antibody was combined with a FITC-conjugated goat anti-rat, cells were permeabilized and the first antibody was incubated for 30 min, followed by 30 min of the second antibody. For all analyses, the percentage of positive cells was referred to the leukocytes, unless otherwise stated. Cells stained with isotype controls (all from BD) as well as unstained cells served as controls.
Real-time reverse transcriptase-PCR (RT-qPCR). For real-time quantitative RT-PCR, total RNA was isolated from decidua, placenta and lymph nodes (inguinal, axillary, mesenteric, iliac). The tissue was treated with Trizol (Gibco, Life Technologies, Darmstadt, Germany) and disaggregated using a homogenator (Ultra Turrax T8; Ika, Staufen, Germany). The RNA was extracted with chloroform, precipitated with absolute ethanol, washed, and finally diluted in RNase-free water. The quantity and quality of the RNA was determined by ultraviolet absorbance at 260 nm. Total RNA (2 mg) was initially incubated with oligo dTs (Amersham Pharmacia, Freiburg, Germany) for 10 min at 75 1C followed by 5 min of incubation on ice. Subtracted mRNA was then incubated with dNTPs (2.5 mmol/l; Amersham Pharmacia), DNase I (2 U/ml, Stratagene, Waldbronn, Germany) and RNase inhibitor (40 U/ml, Promega, Mannheim, Germany) in a reaction buffer. The mix was incubated for 30 min at 37 1C and further heated at 75 1C for 5 min. The addition of the RT (200 U/ml, Promega) and RNase inhibitor in diethyl pyrocarbonate water (diethyl pyrocarbonate was from Sigma) started the reverse transcription. This reaction mixture was incubated at 42 1C for 60 min, followed by incubation at 94 1C for 5 min. Amplification reactions were performed in 13 ml of final reaction volume of SYBR Green Master Mix (Applied Biosystems, Darmstadt, Germany) as follows: initial denaturation at 95 1C for 5 min, followed by 40 cycles of denaturation step at 95 1C for 45 s and annealing step at either 56 1C or 60 1C for 60 s. All samples were normalized to the b-actin transcript levels. All reactions were carried out on an iCycler (Bio-Rad, Munich, Germany). Primer sequences are available upon request.
Western blot analysis. Protein extraction from tissue and cells was performed on ice. Tissue or cells were incubated in lysis buffer (10% NP-40, 0.1 mg/ml n-Dodecil-b-D-maltoside, 500 mM sodium fluoride, 10 mM sodium metavanadate, 100 mM PMSF, 1 M Tris, 0.5 M EDTA and 5 M NaCl) for 60 min. After sonication, cells were centrifuged and supernatants were collected. After overnight storage at À 80 1C, protein content was determined by Bradford assay (Bio-Rad) as indicated by the manufacturers. Then, 50 mg of proteins were resolved on a 15% SDS-PAGE at 80 V for 4 h and transferred onto a 0. Histopathology and immunohistochemistry. Uteri and whole implantation sites were dissected and fixed in either 96% (v/v) ethanol or 4% (v/v) PFA with 0.1 M sucrose, pH 7.4. After dehydration in ethanol, tissue samples were embedded in paraffin. Sections of 5 mm thickness were stained with hematoxylin/ eosin for analysis of morphology and Toluidine blue dye (0.1% aqueous solution or 0.5% in 0.5 N 5 N HCl overnight) for visualizing MCs in the myometrium by the metachromatic staining of secretory granules. The number of MCs was analyzed within the myometrium and calculated per 1 mm 2 by using an Eyepiecemicrometer (Zeiss). To distinguish between mucosal and connective tissue-type MCs, the uterine tissue was stained first with Alcian blue (1% in 3% acetic acid) followed by Safranin (0.5% in 0.125 N HCl). For Mcpt8 staining, slides were boiled in citrate buffer and endogenous peroxidase and protein were blocked. The slides were incubated ON at 4 1C with anti-Mcpt8 (BioLegend) antibody followed by incubation with the secondary antibody goat anti-rat (Jackson Immuno Research, West Grove, PA, USA) for 1 h at RT. Counterstaining was done using hematoxylin.
DBA lectin reacts specifically with uterine NKs on all gestational days and at all stages of differentiation. To identify and quantify the number of uterine NKs, the DBA-lectin staining was done as described elsewhere. 52 Tissue samples for cryosections (whole implantation sites) were embedded in cryo-medium and cut into 5 mm sections. After air-drying, sections were stained with Toluidine blue dye (0.5% in 0.5 N HCl) for identification of MCs. Immunofluorescence for CD117 was performed using a primary antibody from Cedarlane Lab (Burlington, ON, Canada) and FITC-labeled goat anti-rat (Invitrogen) as secondary antibody.
Quantitative histological measurements. The quantitative measurements of the implantation sites as well as placentas were done as described elsewhere 52 by using the software AxioVision4 (Zeiss). Shortly, H/E-stained sections were used to measure the surface area of both the implantation sites on gestation days 5 and 6 as well as the size of the placenta (both in mm 2 ) at a Â 200 magnification. To best characterize the size of the placenta at day 10, we cut 10 serial sections from the central part of each implantation site. This section, which contains the largest placental area, was chosen for the analysis. Then, upon having this clearly defined area we proceeded to determine the surface area as described in Croy et al. 52 This method allows the best possible characterization of the placenta size due to the technical impossibility of dissecting this tissue from the rest at day 10 of pregnancy. The quantitative measurements of the spiral arteries was performed as described elsewhere. 52 Briefly, the spiral artery wall and lumen diameters were measured by using the software AxioVision (Zeiss) and/or expressed as wall/lumen ratios and wall thickness.
Co-culture experiments. The murine trophoblast cell line SM9-2 was propagated in culture in RPMI-1640 with 20% FBS and 1% penicillin/streptomycin, 1 mM sodium pyruvate, 5 Â 10 À 5 M 2-mercapthoethanol, incubated at 37 1C in a humidified atmosphere of 5% CO 2 . PKH26-stained SM9-2 cells were co-cultured with CFDA-SE-stained BMMCs for 48 h and the proliferation of trophoblasts was measured using flow cytometry.
Data analysis and statistics. Data were analyzed using GraphPad Prism5 (Witzenhausen, Germany), expressed as means or medians depending on their distribution (normal or not normal). For data regarding MC quantification, flow cytometry, PCR and in vivo data after BMMC reconstitution, differences among all groups were calculated by the Kruskall-Wallis test and the difference between two independent groups was calculated using the Mann-Whitney U-test. To analyze differences in the implantation numbers in the half of the uterus transferred with BMMCs or with vehicle, the Wilcoxon test was applied. For histological analysis of implantation size at day 5 as well as histological measurements, 1 to 6 implantations and 2 to 10 spiral arteries per female were measured by AxioVision4 (Zeiss), the mean for each specimen was calculated, and the differences between the animal groups analyzed using unpaired t-test. For all tests, P-value of o0.05 was considered to be statistically significant. The number of samples or animals, the statistical test used and the P-values obtained are indicated in each figure or table legend.
